FDAClass IIApril 20, 2022

Separation Technology Creamatocrit Plus recall

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Why was Separation Technology Creamatocrit Plus recalled?

The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Sold between 2019 and 2021

Product
Separation Technology Creamatocrit Plus, Catalog Number: 100-146
Recalling firm
Stanbio Laboratory, LP
Quantity
50
Distribution
US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN
Recall date
April 20, 2022
Classification
Class II
Status
Terminated
Agency
FDA (device)
Open FDA enforcement record Latest recalls